相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dietary Advice to Support Glycaemic Control and Weight Management in Women with Type 1 Diabetes during Pregnancy and Breastfeeding
Lene Ringholm et al.
NUTRIENTS (2022)
Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study
Thomas Danne et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study
Charlotte K. Boughton et al.
DIABETES OBESITY & METABOLISM (2021)
Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes
Sidse Kjaerhus Norgaard et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2021)
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (ONSET 9)
Wendy S. Lane et al.
DIABETES CARE (2020)
Diabetes Management During Breastfeeding in Women with Type 1 Diabetes
Lene Ringholm et al.
CURRENT DIABETES REPORTS (2020)
Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
Charlotte K. Boughton et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial
Bruce W. Bode et al.
DIABETES CARE (2019)
Use of fast-acting insulin aspart in insulin pump therapy in clinical practice
Mark Evans et al.
DIABETES OBESITY & METABOLISM (2019)
A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)
David C. Klonoff et al.
DIABETES OBESITY & METABOLISM (2019)
Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial
Chantal Mathieu et al.
DIABETES OBESITY & METABOLISM (2018)
Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes
Sidse Kjaerhus Norgaard et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial
John B. Buse et al.
DIABETES OBESITY & METABOLISM (2018)
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial
Tim Heise et al.
DIABETES OBESITY & METABOLISM (2017)
A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
Tim Heise et al.
DRUGS & AGING (2017)
Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3)
Helena W. Rodbard et al.
DIABETES OBESITY & METABOLISM (2017)
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial
Keith Bowering et al.
DIABETES CARE (2017)
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes
Tim Heise et al.
CLINICAL PHARMACOKINETICS (2017)
Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Bruce W. Bode et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2017)
Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart
T. Heise et al.
DIABETES OBESITY & METABOLISM (2015)
Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy
H. R. Murphy et al.
DIABETOLOGIA (2012)
HbA1c and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study
S. V. Glinianaia et al.
DIABETOLOGIA (2012)
Hyperglycemia and Adverse Pregnancy Outcomes
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hypoglycemia in pregnant women with type 1 diabetes - Predictors and role of metabolic control
Lene Ringholm Nielsen et al.
DIABETES CARE (2008)
Maternal glycemic control and hypoglycomia in type 1 diabetic pregnancy - A randomized trial of insulin aspart versus human insulin in 322 pregnant women
Elisabeth R. Mathiesen et al.
DIABETES CARE (2007)
分享论文
